$2.29T
Total marketcap
$126.55B
Total volume
BTC 49.72%     ETH 15.79%
Dominance

Agilent Technologies, Inc. AG8.F Stock

135.06 EUR {{ price }} 1.548870% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
39.58B EUR
LOW - HIGH [24H]
135.06 - 135.06 EUR
VOLUME [24H]
150 EUR
{{ volume }}
P/E Ratio
34.63
Earnings per share
3.9 EUR

Agilent Technologies, Inc. Price Chart

Agilent Technologies, Inc. AG8.F Financial and Trading Overview

Agilent Technologies, Inc. stock price 135.06 EUR
Previous Close 109.75 EUR
Open 110.25 EUR
Bid 110.25 EUR x 25800
Ask 111.25 EUR x 25500
Day's Range 110.25 - 110.25 EUR
52 Week Range 105.7 - 151.36 EUR
Volume 243 EUR
Avg. Volume 51 EUR
Market Cap 34.21B EUR
Beta (5Y Monthly) 1.044014
PE Ratio (TTM) 26.95599
EPS (TTM) 3.9 EUR
Forward Dividend & Yield 0.83 (0.76%)
Ex-Dividend Date June 30, 2023
1y Target Est N/A

AG8.F Valuation Measures

Enterprise Value 33.91B EUR
Trailing P/E 26.95599
Forward P/E 27.088451
PEG Ratio (5 yr expected) 4.16
Price/Sales (ttm) 4.8592534
Price/Book (mrq) 5.631033
Enterprise Value/Revenue 4.817
Enterprise Value/EBITDA 16.47

Trading Information

Agilent Technologies, Inc. Stock Price History

Beta (5Y Monthly) 1.044014
52-Week Change 0.52%
S&P500 52-Week Change 20.43%
52 Week High 151.36 EUR
52 Week Low 105.7 EUR
50-Day Moving Average 118.88 EUR
200-Day Moving Average 132.3 EUR

AG8.F Share Statistics

Avg. Volume (3 month) 51 EUR
Avg. Daily Volume (10-Days) 38 EUR
Shares Outstanding 295.38M
Float 294.42M
Short Ratio N/A
% Held by Insiders 0.28%
% Held by Institutions 90.43%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.87
Trailing Annual Dividend Yield 0.79%
5 Year Average Dividend Yield 70.00%
Payout Ratio 0.1916
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends October 31, 2022
Most Recent Quarter (mrq) April 30, 2023
Next Fiscal Year End October 31, 2023

Profitability

Profit Margin 19.18%
Operating Margin (ttm) 25.11%
Gross Margin 54.58%
EBITDA Margin 29.24%

Management Effectiveness

Return on Assets (ttm) 10.40%
Return on Equity (ttm) 24.78%

Income Statement

Revenue (ttm) 7.04B EUR
Revenue Per Share (ttm) 23.7 EUR
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 3.72B EUR
EBITDA 2.06B EUR
Net Income Avi to Common (ttm) 1.35B EUR
Diluted EPS (ttm) 4.09
Quarterly Earnings Growth (yoy) 10.19%

Balance Sheet

Total Cash (mrq) 1.18B EUR
Total Cash Per Share (mrq) 3.98 EUR
Total Debt (mrq) 2.89B EUR
Total Debt/Equity (mrq) 50.01 EUR
Current Ratio (mrq) 2.37
Book Value Per Share (mrq) 19.579

Cash Flow Statement

Operating Cash Flow (ttm) 1.47B EUR
Levered Free Cash Flow (ttm) 867.12M EUR

Profile of Agilent Technologies, Inc.

Country Germany
State CA
City Santa Clara
Address 5301 Stevens Creek Boulevard
ZIP 95051
Phone 800 227 9770
Website https://www.agilent.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 18400

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Q&A For Agilent Technologies, Inc. Stock

What is a current AG8.F stock price?

Agilent Technologies, Inc. AG8.F stock price today per share is 135.06 EUR.

How to purchase Agilent Technologies, Inc. stock?

You can buy AG8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Agilent Technologies, Inc.?

The stock symbol or ticker of Agilent Technologies, Inc. is AG8.F.

Which industry does the Agilent Technologies, Inc. company belong to?

The Agilent Technologies, Inc. industry is Diagnostics & Research.

How many shares does Agilent Technologies, Inc. have in circulation?

The max supply of Agilent Technologies, Inc. shares is 293.06M.

What is Agilent Technologies, Inc. Price to Earnings Ratio (PE Ratio)?

Agilent Technologies, Inc. PE Ratio is 34.63076800 now.

What was Agilent Technologies, Inc. earnings per share over the trailing 12 months (TTM)?

Agilent Technologies, Inc. EPS is 3.9 EUR over the trailing 12 months.

Which sector does the Agilent Technologies, Inc. company belong to?

The Agilent Technologies, Inc. sector is Healthcare.